4. Non-Respiratory Functions of the Lung
1- Vascular reservoir
2- Filter for blood borne substances
3- Defense
4- Endocrine and metabolic functions
5- Pulmonary drug metabolism
6- Platelet formation in the lung
5. Why do I care about PFTs?
• Diagnosis of disease.
• Monitor progression of disease
• Monitor effectiveness of treatment.
• Pre-operative assessment.
6. Standard PFTs
• Spirometry
• Lung volumes
• DLCO
Types of PFTs
Special PFTs
• 6MWD test
• Peak flowmeter
• MIP and MEP
• CPET
19. Preparation of the patient
Precautions:-
1- Don’t smoke for one hour before test.
2- Don’t eat a large meal within 2 hours of test.
3- Please wear loose clothing.
4- Don’t perform exercise within 30 minutes of test.
Withhold bronchodilators:-
SABA: 6 hrs
LABA: 12 hrs
Oral BD (sustained release):24 hrs.
22. Variables that have impact PFT values
• Age.
• Gender.
• Height & weight.
• Race.
23. Acceptability
1. Smooth continuous curve.
2. Lack of artifact induced by coughing.
3. Good start of test, good end of test.
4. Satisfactory exhalation with 6 seconds.
Assessment of the manoeuvers
Reproducibility
After 3 acceptable maneuver, the largest FEV1, FVC should be within 200 ml of each other
26. Restriction
Flow volume loop
1. Relatively unaffected in
restrictive disease
2. Overall size of the curve will
appear smaller when
compared to normal on the
same scale.
29. education for health
DLCO
Increase in the following :
1- Exercise.
2- Supine position.
3- Bronchial asthma.
4- Pulmonary Hemorrhage.
5- Polycythemia.
Decrease in the following :
1- Emphysema.
2- ILD.
3- Anemia.
4- Pulmonary hypertension.
35. Obstructive Severity
• Interpretation of FEV1% predicted:
–>70 % Mild obstruction
–60-70 % Moderate obstruction
–50-60 % Moderately severe obstruction
–35-50 % Severe obstruction
–<35% Very severe obstruction
36. COPD Severity
• According to post bronchodilator FEV1%
predicted:
–>80 % GOLD stage I
–50-80 % GOLD stage II
–30-50 % GOLD stage III
–<30 % GOLD stage IV
37. Small airway obstruction severity
• Interpretation of FEF25-75 % predicted:
–>60 % Normal
–40-60 % Mild obstruction
–20-40 % Moderate obstruction
–<20 % Severe obstruction
38. • Improvement in FEV1 by 12% or
200 ml in repeating spirometry
after treatment with Salbutamol
2.5mg by nebulizer after 15-30
minutes
• Partial reversibility
Reversibility
• Normally (8%).
• Absence of reversibility ??!!
39. Bronchial challenge test
• Other names: bronchial provocation test and
methacholine challenge.
• 20% decrease in FEV1. {PC 20 – FEV1}.
• If PC20 – FEV1 < 1 mg/ml the test provides strong
confirmation of clinical diagnosis of BA.
• If PC20 –FEV1 > 8 mg/ml; BA is unlikely.
• Negative MCT excludes asthma with 95% certainty.